Adma Biologics (ADMA) Current Taxes (2024 - 2026)
Adma Biologics' (ADMA) quarterly Current Taxes came in at $8.6 million in Q4 2025, up 147.52% YoY from $3.5 million in Q4 2024, and up 209.04% on a QoQ basis from $2.8 million in Q3 2025.
Powered by 
Analysis
Adma Biologics (ADMA) Current Taxes (2024 - 2026) Analysis & Trends
Adma Biologics (ADMA) has 2 years of Current Taxes data on file, last reported at $8.6 million in Q4 2025.
- Quarterly Current Taxes rose 147.52% year-over-year to $8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (up 147.52% YoY) and the FY2025 annual result came in at $8.6 million, up 147.52% from the prior year.
- Current Taxes climbed to $8.6 million in Q4 2025, from $2.8 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $8.6 million in Q4 2025 to a low of $2.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Adma Biologics | 2.18 Bn | 2.05 Bn | 86.28 Mn | 6.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.22 Mn |
| Mar 31, 2026 | 17.12 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Jun 30, 2024 | 2.83 Mn |